Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Genome Therapeutics attains milestone in alliance with Schering-Plough

May 11, 1999

Combinations of KRM-1648 with antiinflammatory drugs tested in MAC-infected mice

May 11, 1999

Fluoroquinolones developed at Dainippon with broad-spectrum activity

May 11, 1999

Sankyo's new antibiotics described in patent literature

May 10, 1999

GAR-936, a potent glycylcycline antibiotic with excellent activity against resistant bacteria

May 6, 1999

New carbapenems with good activity against resistant Gram-positive bacteria developed at Merck

May 4, 1999

Licensing opportunity from LG Chemical: broad-spectrum catechol-substituted cephalosporin

May 4, 1999

Micrologix completes phase I trial for prevention of bloodstream infections

May 3, 1999

NDA filed for first oral neuraminidase inhibitor for the flu

April 30, 1999

New oxazolidinones claimed by Zeneca (AstraZeneca)

April 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...